Medical Terms |
ABS | Artificial bowel sphincter |
AFAP | Attenuated variant of familial adenomatous polyposis |
AIN | Anal intraepithelial neoplasia |
APR | Abdominoperineal resection |
ARDS | Acute respiratory distress syndrome |
ASA | Context-dependent: acetylsalicylic acid (medication) |
ASA | Context-dependent: American Society of Anesthesiologists
(→ risk classification) |
ASCA | Anti-Saccharomyces cerevisiae antibodies (Crohn
disease marker) |
ASCUS | Atypical squamous cells of uncertain significance |
ATZ | Anal transitional zone |
BE | Barium enema |
BRBPR | Bright red blood per rectum |
CBC | Complete blood count |
CEA | Carcinoembryonic antigen |
CHRPE | Congenital hypertrophy of the retinal pigment epithelium |
CMV | Cytomegalovirus |
CT | Computed tomography |
DALM | Dysplasia-associated lesion or mass (in ulcerative colitis) |
DIC | Disseminated intravascular coagulation |
DVT | Deep vein thrombosis |
EAS | External anal sphincter |
EGD | Esophagogastroduodenoscopy |
EMG | Electromyogram |
ERUS | Endorectal ultrasound |
FAP | Familial adenomatous polyposis |
FIQL | Fecal incontinence quality of life score |
5-FU | 5-Fluorouracil |
GERD | Gastroesophageal reflux disease |
GI | Gastrointestinal |
GIST | Gastrointestinal stromal tumor |
GYN | Gynecologic |
HAART | Highly active antiretroviral therapy |
HIV | Human immunodeficiency virus |
HNPCC | Hereditary nonpolyposis colon cancer (Lynch I/II) |
H&P | History and physical (examination) |
HPF | High-power field (microscopy) |
HPV | Human papillomavirus |
HSIL | High-grade squamous intraepithelial lesions |
HSV | Herpes simplex virus |
IAS | Internal anal sphincter |
IBD | Inflammatory bowel disease (Crohn disease, ulcerative colitis, indeterminate colitis) |
IBS | Irritable bowel syndrome |
ICU | Intensive care unit |
I&D | Incision and drainage (abscess) |
IMA | Inferior mesenteric artery |
IMRT | Intensity-modulated radiation therapy |
IMV | Inferior mesenteric vein |
IPAA | Ileal J-pouch anal anastomosis |
IPS | Irritable pouch syndrome |
IRA | Ileorectal anastomosis |
LAR | Low anterior resection |
LBO | Large bowel obstruction |
LGV | Lymphogranuloma venereum |
LIS | Lateral internal sphincterotomy |
LLQ | Left lower quadrant |
LSIL | Low-grade squamous intraepithelial lesions |
LUQ | Left upper quadrant |
LV | Leucovorin |
MACE | Malone antegrade colonic enema |
MAP | MYH-associated polyposis |
MELD | Model for end-stage liver disease |
MRCP | Magnetic resonance cholangiopancreatography |
MRI | Magnetic resonance imaging |
MRSA | Methicillin-resistant Staphylococcus aureus |
MSI | Microsatellite instability |
MSM | Men who have sex with men |
MSS | Microsatellite stability |
NGT | Nasogastric tube |
NPO | Nothing by mouth (nulla per os) |
NSAID | Nonsteroidal anti-inflammatory drug |
O&P | Ova and parasites |
OR | Operating room |
pANCA | Perinuclear antineutrophil cytoplasmic antibodies (marker
for ulcerative colitis) |
PC/IPAA | Proctocolectomy/ileal J-pouch anal anastomosis |
PE | Pulmonary embolism |
PET | Positron emission tomography |
PET-CT | Positron emission tomography combined with CT |
PID | Pelvic inflammatory disease |
POD | Postoperative day |
PPD | Purified protein derivative (tuberculosis test) |
PPH | Procedure for prolapse and hemorrhoids |
PSARP | Posterior sagittal anorectoplasty |
PSC | Primary sclerosing cholangitis |
PT | Prothrombin time |
PTT | Partial thromboplastin time |
RAIR | Rectoanal inhibitory reflex |
RBC | Red blood cell |
RLQ | Right lower quadrant |
RUQ | Right upper quadrant |
SBO | Small bowel obstruction |
SCC | Squamous cell cancer |
SCFA | Short-chain fatty acids |
SMA | Superior mesenteric artery |
SMV | Superior mesenteric vein |
SRUS | Solitary rectal ulcer syndrome |
STD | Sexually transmitted disease |
TEM | Transanal endoscopic microsurgery |
TIPS | Transjugular intrahepatic portosystemic shunt |
TME | Total mesorectal excision |
TNM | Tumor nodes metastases (tumor staging system) |
TPN | Total parenteral nutrition |
UC | Ulcerative colitis |
VAC | Vacuum-assisted closure |
WBC | White blood cells |
XRT | Chemoradiation |
Oncological Outcome Parameters |
DFS | Disease-free survival |
NED | No evidence of disease (cancer follow-up) |
ORR | Objective response rate (sum of complete and partial response) |
OS | Overall survival | ...